Two top Healthcare IPOs Supported by Frost & Sullivan in 2012

Informations

• Publié par: frost-sullivan
• Nombre de lectures: 25
• Langue: English

Extrait

Two top Healthcare IPOs Supported by Frost & Sullivan in 2012

PR Newswire LONDON, Dec. 13, 2012

- The growth consulting company has helped MD Medical Group's listing inLondon, after assisting IHH Healthcare

LONDON, Dec. 13, 2012 /PRNewswire/ -- Frost & Sullivan has supported the initial public offering of MD Medical Group (MDMG) on the London Stock Exchange (LSE) in the largest European IPO in the healthcare service space this year.

Earlier, Frost & Sullivan assisted IHH Healthcare w ith itsUS$2 billionIPO – the fourth largest IPO globally in 2012, in Singapore and Kuala Lumpur. Additionally, Frost & Sullivan supported the Malaysian palm oil producer, Felda Global Ventures (US$3.2 billion), the third largest IPO this year, after Facebook and Japan Airlines.

MD Medical Group (MDMG) operates in the highly attractive Russian private healthcare service market, and has a leading position in high-quality women's health and paediatrics. The company manages ten modern healthcare facilities, including two hospitals and eight outpatient clinics in Moscow, St. Petersburg, Ufa and Perm. Also, MDMG operates two franchised outpatient clinics operate in Kyiv and one in Irkutsk.

MDMG raisedUS$ 289 millionin the IPO which valued the company atUS$ 901 million. Deutsche Bank and JP Morgan acted as Joint Global Coordinators and Joint Book Runners in connection with the transaction.

Commenting on the announcement, Vitaly Ustimenko, C FO at MDMG, said: "We are the first Russian healthcare services company to attract financing on the London Stock Exchange. Proceeds of the offering will be used to further expand our operations and to finance the construction of the new hospital in Ufa. We had a very positive experience in working with Frost & Sullivan. I would like to particularly highlight their sound commercial analysis and an extremely professional, responsive, and committed team."

Andrew Calvert, Director of Frost & Sullivan's Financial Services practice, said: "MDMG is a great com pany and was well received by the investment community. I am delighted that we were able to support MDMG in its IPO and am bullish about the company's ability to continue to capitalise on the market dynamics which have contributed to its success. Growth in disposable income, further government support and increasing demand for quality healthcare create the macro conditions in which ambitious, organised and dynamic companies such as MDMG can succeed."

Jaime Martinez, a Consultant in Frost & Sullivan's Financial Services practice, added: "We are confident that MDMG will expand its presence in the women and child healthcare segments, which are amongst the fastest growing in the Russian healthcare services system. The ability to leverage the combined IPO and healthcare services expertise of our Financial Services and Healthcare practices as well as our local presence and expertise in Moscow was key. It was a pleasure to work with MDMG and its advisors throughout the process."

To find out more about Frost & Sullivan'sInitial Public Offering (IPO) Services, please send an email with your contact details to Anna Zanchi, Corporate Communications, at [e-mail]

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, w orks in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

The Integrated Value Propositionprovides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation. The Partnership Infrastructureis entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of m ore than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us: Start the discussion